You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
熱景生物(688068.SH):參股公司舜景醫藥擬增資 公司放棄本次增資的優先認購權

格隆匯8月13日丨熱景生物(688068.SH)公佈,熱景生物於2025年8月12日召開第四屆董事會第二次會議,審議通過了《關於參股公司增資暨關聯交易的議案》,山證創新、海南樹澤、人才科創、林長青,擬共同以現金對公司參股公司舜景醫藥進行增資,增資價格爲25元/註冊資本,增資總金額爲10,000萬元。本次增資完成後,舜景醫藥的註冊資本將由原7,200萬元增加至7,600萬元,公司持有舜景醫藥的股權比例由45.5833%下降至43.1842%。公司擬放棄本次增資的優先認購權。

舜景醫藥是公司持股45.5833%的參股公司,林長青先生系公司控股股東、實際控制人、董事長和總經理,並擔任舜景醫藥法定代表人、董事長、經理,公司副總經理、董事會祕書石永沾先生擔任舜景醫藥財務負責人,根據《上海證券交易所科創板股票上市規則》的規定,舜景醫藥、林長青爲公司的關聯方。公司作爲舜景醫藥的股東,放棄對舜景醫藥本次增資的優先認購權,構成關聯交易。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account